129 related articles for article (PubMed ID: 10667483)
1. Tumor markers in lung cancer: does the method of obtaining the cut-off point and reference population influence diagnostic yield?
Pina TC; Zapata IT; López JB; Pérez JL; Paricio PP; Hernández PM
Clin Biochem; 1999 Aug; 32(6):467-72. PubMed ID: 10667483
[TBL] [Abstract][Full Text] [Related]
2. Identifying the Best Marker Combination in CEA, CA125, CY211, NSE, and SCC for Lung Cancer Screening by Combining ROC Curve and Logistic Regression Analyses: Is It Feasible?
Yang Q; Zhang P; Wu R; Lu K; Zhou H
Dis Markers; 2018; 2018():2082840. PubMed ID: 30364165
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic values of SCC, CEA, Cyfra21-1 and NSE for lung cancer in patients with suspicious pulmonary masses: a single center analysis.
Chu XY; Hou XB; Song WA; Xue ZQ; Wang B; Zhang LB
Cancer Biol Ther; 2011 Jun; 11(12):995-1000. PubMed ID: 21483235
[TBL] [Abstract][Full Text] [Related]
4. [Diagnostic value of serum tumor markers in differentiating malignant from benign solitary pulmonary nodules].
Ni LF; Liu XM
Beijing Da Xue Xue Bao Yi Xue Ban; 2014 Oct; 46(5):707-10. PubMed ID: 25331391
[TBL] [Abstract][Full Text] [Related]
5. Serum CEA, CA125, and SCC antigens and tumor recurrence in resectable non-small cell lung cancer.
Diez M; Gomez A; Hernando F; Ortega MD; Maestro ML; Torres A; Mugüerza JM; Gutierrez A; Granell J; Balibrea JL
Int J Biol Markers; 1995; 10(1):5-10. PubMed ID: 7629428
[TBL] [Abstract][Full Text] [Related]
6. The prognostic values of CA125, CA19.9, NSE, AND SCC for stage I NSCLC are limited.
Ma S; Shen L; Qian N; Chen K
Cancer Biomark; 2011-2012; 10(3-4):155-62. PubMed ID: 22674301
[TBL] [Abstract][Full Text] [Related]
7. Increased lung cancer risk in patients with interstitial lung disease and elevated CEA and CA125 serum tumour markers.
Dai H; Liu J; Liang L; Ban C; Jiang J; Liu Y; Ye Q; Wang C
Respirology; 2014 Jul; 19(5):707-13. PubMed ID: 24903079
[TBL] [Abstract][Full Text] [Related]
8. Cut-off-independent tumour marker evaluation using ROC approximation.
Bitterlich N; Schneider J
Anticancer Res; 2007; 27(6C):4305-10. PubMed ID: 18214036
[TBL] [Abstract][Full Text] [Related]
9. Human Epididymis Protein 4 (HE4) in Patients with Small-Cell Lung Cancer.
Wojcik E; Tarapacz J; Rychlik U; Stasik Z; Sas-Korczynska B; Skotnicki P; Kulpa JK
Clin Lab; 2016 Sep; 62(9):1625-1632. PubMed ID: 28164590
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of chest radiography, computed tomography and tumour markers in the differentiation of malignant from benign solitary pulmonary lesions.
Seemann MD; Seemann O; Dienemann H; Schalhorn A; Prime G; Fink U
Eur J Med Res; 1999 Aug; 4(8):313-27. PubMed ID: 10471543
[TBL] [Abstract][Full Text] [Related]
11. [Clinical Significance of Tumor Marker Detection in Patients
with Advanced Squamous Cell Carcimoma of the Lung].
Liang P; Li J
Zhongguo Fei Ai Za Zhi; 2016 Oct; 19(10):641-647. PubMed ID: 27760591
[TBL] [Abstract][Full Text] [Related]
12. Utility of squamous cell carcinoma antigen, carcinoembryonic antigen, Cyfra 21-1 and neuron specific enolase in lung cancer diagnosis: a prospective study from China.
Song WA; Liu X; Tian XD; Wang W; Liang CY; Zhang T; Guo JT; Peng YH; Zhou NK
Chin Med J (Engl); 2011 Oct; 124(20):3244-8. PubMed ID: 22088515
[TBL] [Abstract][Full Text] [Related]
13. A system for tumor heterogeneity evaluation and diagnosis based on tumor markers measured routinely in the laboratory.
Hui L; Rixv L; Xiuying Z
Clin Biochem; 2015 Dec; 48(18):1241-5. PubMed ID: 26216289
[TBL] [Abstract][Full Text] [Related]
14. Thymidine kinase 1 combined with CEA, CYFRA21-1 and NSE improved its diagnostic value for lung cancer.
Jiang ZF; Wang M; Xu JL
Life Sci; 2018 Feb; 194():1-6. PubMed ID: 29247745
[TBL] [Abstract][Full Text] [Related]
15. CEA, SCC and NSE levels in exhaled breath condensate--possible markers for early detection of lung cancer.
Zou Y; Wang L; Zhao C; Hu Y; Xu S; Ying K; Wang P; Chen X
J Breath Res; 2013 Dec; 7(4):047101. PubMed ID: 24185583
[TBL] [Abstract][Full Text] [Related]
16. [Diagnostic value of combined detection of TPS, NSE and CEA in lung cancer].
Zheng H; He BF; Luo RC
Di Yi Jun Yi Da Xue Xue Bao; 2003 Feb; 23(2):165-6. PubMed ID: 12581971
[TBL] [Abstract][Full Text] [Related]
17. Clinical evaluation of seven tumour markers in lung cancer diagnosis: can any combination improve the results?
Plebani M; Basso D; Navaglia F; De Paoli M; Tommasini A; Cipriani A
Br J Cancer; 1995 Jul; 72(1):170-3. PubMed ID: 7541234
[TBL] [Abstract][Full Text] [Related]
18. The reference intervals for CA125, CA15-3, CA19-9, CA72-4, AFP, CEA, NSE and CYFRA21-1.
Yang J; Tang A; Ma J; Sun X; Ming L
Scand J Clin Lab Invest; 2019; 79(1-2):71-74. PubMed ID: 30727773
[TBL] [Abstract][Full Text] [Related]
19. [Tumor markers in pleural effusion of patients with lung cancer and patients with tuberculous pleurisy].
Tada A; Kawai H; Matsumoto H; Kimura G; Okada C; Soda R; Takahashi K
Nihon Kokyuki Gakkai Zasshi; 2002 Feb; 40(2):106-12. PubMed ID: 11974864
[TBL] [Abstract][Full Text] [Related]
20. [Diagnostic usefulness of selected tumor markers (CA125, CEA, CYFRA 21-1) in bronchoalveolar lavage fluid in patients with non-small cell lung cancer].
Dabrowska M; Grubek-Jaworska H; Domagała-Kulawik J; Bartoszewicz Z; Kondracka A; Krenke R; Nejman P; Chazan R
Pol Arch Med Wewn; 2004 Jun; 111(6):659-65. PubMed ID: 15508787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
